First National Bank of Omaha’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$14.1M Buy
15,455
+407
+3% +$413K 0.44% 52
2025
Q4
$16.2M Buy
15,048
+5,035
+50% +$4.81M 0.48% 44
2025
Q3
$7.64M Sell
10,013
-406
-4% -$302K 0.48% 57
2025
Q2
$8.12M Sell
10,419
-187
-2% -$145K 0.52% 53
2025
Q1
$8.76M Sell
10,606
-1,275
-11% -$1.06M 0.6% 48
2024
Q4
$9.17M Sell
11,881
-1
-0% -$828 0.6% 51
2024
Q3
$10.5M Sell
11,882
-1,104
-9% -$993K 0.67% 42
2024
Q2
$11.8M Buy
12,986
+2,380
+22% +$1.9M 0.77% 30
2024
Q1
$8.76M Sell
10,606
-8,360
-44% -$5.95M 0.6% 48
2023
Q4
$11.1M Sell
18,966
-6,732
-26% -$3.93M 0.7% 37
2023
Q3
$13.8M Sell
25,698
-7,319
-22% -$3.77M 0.9% 25
2023
Q2
$15.5M Sell
33,017
-11,832
-26% -$4.96M 0.89% 22
2023
Q1
$15.4M Sell
44,849
-1,969
-4% -$664K 0.93% 21
2022
Q4
$17.1M Sell
46,818
-3,455
-7% -$1.22M 1.06% 16
2022
Q3
$16.3M Sell
50,273
-1,158
-2% -$367K 1.06% 14
2022
Q2
$16.7M Sell
51,431
-1,327
-3% -$398K 1.01% 18
2022
Q1
$15.1M Buy
52,758
+3,698
+8% +$952K 0.77% 29
2021
Q4
$13.6M Sell
49,060
-2,493
-5% -$632K 0.65% 40
2021
Q3
$11.9M Sell
51,553
-4,074
-7% -$1.01M 0.6% 48
2021
Q2
$10.4M Hold
55,627
0.54% 54
2021
Q1
$10.4M Sell
55,627
-7,068
-11% -$1.38M 0.54% 54
2020
Q4
$10.6M Sell
62,695
-313
-0.5% -$46.7K 0.57% 49
2020
Q3
$9.33M Sell
63,008
-1,404
-2% -$217K 0.58% 53
2020
Q2
$10.6M Sell
64,412
-8,826
-12% -$1.35M 0.71% 38
2020
Q1
$10.2M Sell
73,238
-1,304
-2% -$179K 0.79% 31
2019
Q4
$9.8M Sell
74,542
-3,252
-4% -$377K 0.59% 50
2019
Q3
$8.7M Sell
77,794
-2,500
-3% -$278K 0.56% 54
2019
Q2
$8.9M Sell
80,294
-8,513
-10% -$1M 0.58% 52
2019
Q1
$11.5M Sell
88,807
-8,258
-9% -$1M 0.79% 29
2018
Q4
$11.2M Sell
97,065
-3,693
-4% -$413K 0.85% 25
2018
Q3
$10.8M Sell
100,758
-583
-0.6% -$58.3K 0.61% 38
2018
Q2
$8.65M Buy
101,341
+824
+0.8% +$67.7K 0.51% 53
2018
Q1
$7.78M Sell
100,517
-138
-0.1% -$11.1K 0.46% 64
2017
Q4
$8.5M Sell
100,655
-3,210
-3% -$273K 0.5% 55
2017
Q3
$8.88M Sell
103,865
-13,944
-12% -$1.14M 0.54% 50
2017
Q2
$9.7M Sell
117,809
-3,821
-3% -$312K 0.61% 41
2017
Q1
$10.2M Sell
121,630
-3,340
-3% -$268K 0.62% 37
2016
Q4
$9.19M Buy
124,970
+2,451
+2% +$183K 0.57% 44
2016
Q3
$9.83M Buy
122,519
+2,475
+2% +$198K 0.72% 34
2016
Q2
$9.45M Buy
120,044
+15,532
+15% +$1.17M 0.7% 40
2016
Q1
$7.53M Sell
104,512
-113
-0.1% -$8.55K 0.56% 58
2015
Q4
$8.82K Buy
104,625
+81,736
+357% +$6.78M 0.63% 46
2015
Q3
$1.92K Sell
22,889
-862
-4% -$72.8K 0.14% 163
2015
Q2
$1.71K Hold
23,751
0.12% 172
2015
Q1
$1.71K Sell
23,751
-400
-2% -$28.5K 0.12% 172
2014
Q4
$1.67M Buy
24,151
+826
+4% +$55.8K 0.12% 176
2014
Q3
$1.51M Sell
23,325
-405
-2% -$25.6K 0.11% 182
2014
Q2
$1.48M Sell
23,730
-70
-0.3% -$4.18K 0.1% 184
2014
Q1
$1.4M Sell
23,800
-1,325
-5% -$73.9K 0.1% 180
2013
Q4
$1.28M Sell
25,125
-1,294
-5% -$64.8K 0.1% 184
2013
Q3
$1.33M Hold
26,419
0.12% 169
2013
Q2
$1.3K Buy
+26,419
New +$1.44M 0.11% 167

Other funds holding LLY

First National Bank of Omaha's LLY Position: Q1 2026 in Review

First National Bank of Omaha increased its Eli Lilly (LLY) stake by 2.7% in Q1 2026, buying an estimated $413K and bringing the position to 15,455 shares worth $14.1M. The position accounts for 0.44% of the portfolio, ranked #52.

First National Bank of Omaha first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $17.1M in Q4 2022. 4,358 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • First National Bank of Omaha held 15,455 shares of Eli Lilly worth $14.1M as of Q1 2026.
  • First National Bank of Omaha bought 407 Eli Lilly shares in Q1 2026, an estimated $413K.
  • Eli Lilly made up 0.44% of First National Bank of Omaha's portfolio in Q1 2026, its #52 holding.
  • First National Bank of Omaha first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • First National Bank of Omaha's Eli Lilly position peaked at $17.1M in Q4 2022.
  • 4,358 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on First National Bank of Omaha's 13F filing for Q1 2026, filed 11 May 2026.